Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects
Publisher: John Wiley & Sons Inc
E-ISSN: 2160-7648|2|4|387-393
ISSN: 2160-763X
Source: Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 387-393
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract